Search Within

Joachim Yahalom

  1. "David Straus"
Formats
  1. Meeting Abstract (38)
  2. Journal Article (34)
  3. Book Section (9)
  4. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (82)
  2. Department of Medicine (82)
  3. Hematologic Malignancies, Division of (82)
  4. Lymphoma (82)
  5. Radiation Oncology, Department of (82)
  6. Survivorship Research (82)

More Groups

People
  1. David Straus (82)
  2. Andrew Zelenetz (59)
  3. Ariela Noy (52)
  4. Steven Horwitz (44)
  5. Paul Hamlin (39)
  6. Alison Moskowitz (37)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (7)
  5. 2020 (5)
  6. 2019 (5)

More Years

Publications
  1. Blood (31)
  2. Journal of Clinical Oncology (9)
  3. Hematological Oncology (8)
  4. Blood Advances (4)
  5. British Journal of Haematology (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (35)
  2. Wiley Blackwell (10)
  3. American Society of Clinical Oncology (9)
  4. CMP Healthcare Media (4)
  5. PRR, Inc. (4)
  6. Elsevier Inc. (3)

More Publishers

Results (82)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 5th ed (2001)

    Fulltext@MSK | Save
  • Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease
    Meeting Abstract

    Straus, D. J.; Yahalom, J.; Zelenetz, A. D.; Qin, J.; Myers, J.; Moskowitz, C. H.; Noy, A.; Bertino, J. R.; Portlock, C. S.
    Blood (2001)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 3rd ed (1999)

    Fulltext@MSK | Save
  • Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant- eligible patients with non-Hodgkin's lymphoma
    Journal Article

    Moskowitz, C. H.; Bertino, J. R.; Glassman, J. R.; Hedrick, E. E.; Hunte, S.; Coady-Lyons, N.; Agus, D. B.; Goy, A.; Jurcic, J.; Noy, A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Glassman, J. R.; Portlock, C. S.; Yahalom, J.; Straus, D. J.; O'Brien, J. P.; Elkin, N.; Bertino, J. R.; Zelenetz, A. D.
    Bone Marrow Transplantation (1999)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 2nd ed (1998)

    Fulltext@MSK | Save
  • Impact of initial response on disease progression following tandem peripheral blood stem-cell transplants (PBSCT) in patients (pts) with poor prognosis multiple myeloma (MM)
    Meeting Abstract

    Niesvizky, R.; Choy, C. G.; Fine, J.; Glassman, J.; Reich, L.; Straus, D.; Yahalom, J.; Zhu, A.; Michaeli, J.
    Blood (1998)

    Fulltext@MSK | Save
  • Th use of stanford v overcomes poor prognostic features in patients with advanced stage Hodgkin's disease (HD)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Straus, D.; Portlock, C. S.; Goy, A.; O'Brien, J. P.; Zelenetz, A. D.
    Blood (1998)

    Fulltext@MSK | Save